Bharat Biotech sets up CRDMO arm to focus on cell and gene therapies
Bharat Biotech launches Nucelion Therapeutics, a CRDMO focused on advanced cell and gene therapies for global life science innovators. File Vaccine maker Bharat Biotech has established a contract research development and manufacturing organisation (CRDMO) focused on cell and gene therapies. Setting up of the wholly-owned subsidiary Nucelion Therapeutics is part of a strategic expansion into…
Read More “Bharat Biotech sets up CRDMO arm to focus on cell and gene therapies” »